Brain Imaging and Developmental Follow up of Infants Treated With Erythropoietin

Completed

Conditions studied: Prematurity

In brief

Approximately 60,000 premature infants are born each year who weigh less than 1,500 grams,many of whom sustain brain damage because of their prematurity. This study is designed to evaluate the long-term developmental effects of one promising neuroprotective treatment,erythropoietin (Epo), when given in the neonatal period. Using detailed neurodevelopmental testing and state-of-the-art brain imaging, we hope to determine whether this is an effective treatment to prevent brain injury associated with prematurity, and to lay the groundwork for further studies to improve the developmental outcome of infants delivered prematurely.

Key facts

Study ID
NCT01207778
Run by
University of New Mexico
People needed
77
Starts
2010-03-01
Expected to finish
2020-12-31
Last updated by the study team
2023-08-04

Who can join

Age: 3 and older, up to 6. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.